Balance Sheet
Accounts PayablesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Cash & Equivalents: 2020-2024

Historic Cash & Equivalents for MDxHealth (MDXH) over the last 5 years, with Dec 2024 value amounting to $46.8 million.

  • MDxHealth's Cash & Equivalents fell 35.03% to $32.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $32.0 million, marking a year-over-year decrease of 35.03%. This contributed to the annual value of $46.8 million for FY2024, which is 109.12% up from last year.
  • As of FY2024, MDxHealth's Cash & Equivalents stood at $46.8 million, which was up 109.12% from $22.4 million recorded in FY2023.
  • Over the past 5 years, MDxHealth's Cash & Equivalents peaked at $58.5 million during FY2021, and registered a low of $15.5 million during FY2022.
  • In the last 3 years, MDxHealth's Cash & Equivalents had a median value of $34.6 million in 2023 and averaged $35.8 million.
  • In the last 5 years, MDxHealth's Cash & Equivalents surged by 266.69% in 2021 and then tumbled by 73.50% in 2022.
  • MRY analysis of 5 years shows MDxHealth's Cash & Equivalents stood at $16.0 million in 2020, then surged by 266.69% to $58.5 million in 2021, then tumbled by 73.50% to $15.5 million in 2022, then skyrocketed by 44.36% to $22.4 million in 2023, then soared by 109.12% to $46.8 million in 2024.
  • Its Cash & Equivalents stands at $46.8 million for FY2024, versus $22.4 million for FY2023 and $15.5 million for FY2022.